Cartesian Therapeutics (RNAC) Capital Expenditures (2015 - 2026)
Cartesian Therapeutics (RNAC) posted quarterly Capital Expenditures of $27000.0 for Q1 2026, down 97.49% year-over-year from $1.1 million in Q1 2025, and down 99.49% quarter-over-quarter from $5.3 million in Q4 2025.
Cartesian Therapeutics (RNAC) Capital Expenditures (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Capital Expenditures for 12 consecutive years, with $27000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 97.49% year-over-year to $27000.0; the TTM figure through Mar 2026 stood at $4.4 million (up 129.24% YoY), while the FY2025 annual figure was $5.5 million, up 543.92% from the prior year.
- Capital Expenditures fell to $27000.0 in Q1 2026 per RNAC's latest filing, from $5.3 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $5.3 million in Q4 2025 and bottomed at -$1.8 million in Q3 2024.
- Historically, Capital Expenditures has averaged $478562.5 across 5 years, with a median of $77000.0 in 2022.
- On a YoY basis, Capital Expenditures climbed as much as 2769.51% in 2024 and fell as far as 10670.59% in 2024.
- Cartesian Therapeutics' Capital Expenditures stood at $1.1 million in 2022, then plunged by 94.03% to $63000.0 in 2023, then jumped by 622.22% to $455000.0 in 2024, then surged by 1074.29% to $5.3 million in 2025, then sank by 99.49% to $27000.0 in 2026.
- Business Quant data shows RNAC's Capital Expenditures at $27000.0 in Q1 2026, $5.3 million in Q4 2025, and -$577000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Cartesian Therapeutics | 265.54 Mn | 265.54 Mn | - | 240,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 240,000.00 |
| Jun 30, 2026 | 240,000.00 |
| Mar 31, 2026 | 27,000.00 |
| Mar 31, 2026 | 27,000.00 |
| Dec 31, 2025 | 5.34 Mn |
| Dec 31, 2025 | 5.34 Mn |
| Sep 30, 2025 | -577,000.00 |
| Sep 30, 2025 | -577,000.00 |
| Jun 30, 2025 | -387,000.00 |
| Jun 30, 2025 | -387,000.00 |
| Mar 31, 2025 | 1.08 Mn |
| Mar 31, 2025 | 1.08 Mn |
| Dec 31, 2024 | 455,000.00 |
| Dec 31, 2024 | 455,000.00 |
| Sep 30, 2024 | -1.80 Mn |
| Sep 30, 2024 | -1.80 Mn |
| Jun 30, 2024 | 2.19 Mn |
| Jun 30, 2024 | 2.19 Mn |
| Dec 31, 2023 | 63,000.00 |
| Dec 31, 2023 | 63,000.00 |